Clinical Trial Update: Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy

View source ↗

Summary

This completed clinical trial reports mid-to-long-term outcomes for CML patients who achieved complete cytogenetic response on first-line imatinib. The findings…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Chronic Myeloid Leukemia | Status: COMPLETED